TrialBMC cancer2017

Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.

T Yokota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.